Featured Stories
PIH Applauds Breakthrough in Access to Key MDR-TB Drug
Johnson & Johnson pledges not to enforce bedaquiline patents, opening pathway for generic drug manufacturing Posted on Oct 27, 2023 Following Friday’s precedent-setting announcement that in low- and middle-income countries Johnson & Johnson will not enforce patents on bedaquiline, a key drug in the fight against multidrug-resistant tuberculosis (MDR-TB), Partners Read more…